Medicare Enrolled

Dr. Anil Gogineni, M.D.

Internal Medicine · Ocala, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1834 SW 1ST AVE, Ocala, FL 34471
3527325552
In practice since 2008 (18 years)
NPI: 1821267386 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gogineni from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gogineni? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gogineni

Dr. Anil Gogineni is an internal medicine specialist in Ocala, FL, with 18 years of NPI registration. Based on federal Medicare data, Dr. Gogineni performed 4,750 Medicare services across 3,643 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gogineni received a total of $159,647 from 52 pharmaceutical and/or device companies across 681 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gogineni is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 8% volume in FL $159,647 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 100227 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
4,750
Medicare services
Top 8% in FL for internal medicine
3,643
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~264 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity 1,046 $96 $180
Initial hospital admission, high complexity 684 $140 $264
Office visit, established patient (20-29 min) 524 $65 $139
Critical care, first 30-74 min 429 $173 $415
Hospital follow-up visit, moderate complexity 338 $64 $120
Office visit, established patient (30-39 min) 277 $98 $190
Test to measure expiratory airflow and volume changes before and after medication administration 251 $28 $88
Test to examine how well the lungs exchange gases 251 $42 $67
Test to determine lung volumes using gas dilution or washout 165 $31 $65
New patient office visit (45-59 min) 106 $130 $250
Test to determine lung volumes using sensors 85 $41 $65
Blood sodium level 47 $5 $8
Artery puncture collection of blood sample 45 $18 $40
Carboxyhemoglobin (protein) level 45 $12 $25
Blood gases measurement, with o2 saturation 45 $77 $90
Methemoglobin (hemoglobin) analysis, quantitative 45 $8 $9
Blood potassium level 45 $5 $8
Blood count, hemoglobin 45 $2 $5
Aspiration of initial secretion of lung airway using an endoscope 39 $115 $313
Smoking and tobacco use intensive counseling, 4-10 minutes 33 $15 $22
Sleep study in sleep lab (6 years or older) 32 $457 $1,000
Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes 30 $10 $20
Test for exercise-induced lung stress 29 $25 $60
Diagnostic exam of lung airway using an endoscope 19 $106 $253
Sleep study including heart rate, breathing, airflow, and effort 16 $72 $300
Emergent insertion of breathing tube into windpipe using an endoscope 15 $116 $352
Insertion of non-tunneled central venous tube for infusion (5 years or older) 14 $68 $283
Biopsy of lobe of lung using an endoscope, 1 lobe 13 $56 $260
Needle biopsy of windpipe cartilage, airway, and/or lung using an endoscope 13 $127 $303
Irrigation and suction of lung airways to obtain cells using an endoscope 12 $19 $390
Therapy procedure using a positive pressure ventilator 12 $50 $82
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
0.5% medium
99.2% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$159,647
Total received (2018-2024)
Avg $22,807/year across 7 years
Top 1% in FL for internal medicine
52
Companies
681
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$146,266 (91.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,551 (6.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$3,830 (2.4%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$10,901
2023
$33,438
2022
$26,976
2021
$14,870
2020
$23,638
2019
$32,900
2018
$16,923

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$63,364
Boehringer Ingelheim Pharmaceuticals, Inc.
$34,731
Grifols USA, LLC
$20,282
Sunovion Pharmaceuticals Inc.
$19,680
Mylan Specialty L.P.
$12,601
AstraZeneca Pharmaceuticals LP
$1,640
Intuitive Surgical, Inc.
$1,137
Janssen Pharmaceuticals, Inc
$662
Grifols Shared Services North America, Inc.
$660
Philips Electronics North America Corporation
$652
GENZYME CORPORATION
$598
ABIOMED
$524
Regeneron Healthcare Solutions, Inc.
$280
Electromed, Inc.
$273
Insmed, Inc.
$234
Pulmonx Corporation
$231
Ethicon Inc.
$222
Genentech USA, Inc.
$143
Bayer HealthCare Pharmaceuticals Inc.
$142
Takeda Pharmaceuticals U.S.A., Inc.
$141
Allergan Inc.
$126
HARMONY BIOSCIENCES LLC
$125
AcelRx Pharmaceuticals, Inc.
$120
La Jolla Pharmaceutical Company
$119
Novartis Pharmaceuticals Corporation
$109
JAZZ PHARMACEUTICALS INC.
$107
Actelion Pharmaceuticals US, Inc.
$78
ZOLL Respicardia, Inc.
$73
Amgen Inc.
$57
Jazz Pharmaceuticals Inc.
$50
United Therapeutics Corporation
$47
Harmony Biosciences Llc
$45
Merck Sharp & Dohme Corporation
$33
PFIZER INC.
$27
Merck Sharp & Dohme LLC
$26
Avadel CNS Pharmaceuticals, LLC
$26
Alexion Pharmaceuticals, Inc.
$25
Penumbra, Inc.
$24
Melinta Therapeutics, Inc.
$24
Gilead Sciences, Inc.
$22
Covis Pharma GmBH
$20
Fisher & Paykel Healthcare Inc
$20
Inogen, Inc.
$19
Tactile Systems Technology Inc
$18
Hikma Pharmaceuticals USA
$17
Baxter Healthcare
$16
Boston Scientific Corporation
$15
Philips North America LLC
$15
INOGEN, INC.
$12
PORTOLA PHARMACEUTICALS, LLC
$12
Nabriva Therapeutics, plc
$12
Breathe Technologies, Inc.
$11
Top 3 companies account for 74.1% of total payments
Associated products mentioned in payments ›
(2809) Trilogy 100 · (8874) InCourage · (8874) inCourage · (AK6) Vest Therapy · AIRSUPRA · ANDEXXA · ANORO · ANORO ELLIPTA · AREXVY · AVYCAZ · Adempas · Arikayce · BEVESPI AEROSPHERE · BEXSERO · BREO · BREZTRI · Baxdela · CHANTIX · CHARTIS CATHETER · DALVANCE · DSUVIA · DUPIXENT · Da Vinci Surgical System · ENTRESTO · EXALT Model D · Esbriet · FASENRA · FISHER & PAYKEL HEALTHCARE · Flexitouch Plus · GIAPREZA · GLASSIA · Hillrom - Life 2000 Ventilation System · IMFINZI · INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH · Impella · Indigo System · KEYTRUDA · LIFE2000 · LONHALA MAGNAIR · LUMRYZ · Monarch Platform · NUCALA · OFEV · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Perforomist · Prolastin-C · Prolastin-C Liquid · Respiratoriy Care Undiv · Ryaltris · SHINGRIX · SMARTVEST · SOLIRIS · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · TEZSPIRE · TRELEGY ELLIPTA · TUDORZA PRESSAIR · TYVASO · Trilogy 100 · UPTRAVI · Utibron · WAKIX · Wakix · XARELTO · XOLAIR · XYREM · XYWAV · Xembify · Xenleta · Xolair · YUPELRI · Yupelri · ZERBAXA · inCourage · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for internal medicine in FL.

Equivalent to $3,361 per 100 Medicare services performed
Looking for an internal medicine specialist in Ocala?
Compare internal medicine physicians in the Ocala area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
240
Per 100K population
61.9
County median income
$58,535
Nearest hospital
MARION COMMUNTIY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Gogineni is a clinical cardiology specialist, with above-average Medicare volume (top 8% in FL), with speaking/promotional industry engagement in the top 1% of FL peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Gogineni experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Gogineni performed 1,046 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gogineni receive payments from pharmaceutical companies?
Yes. Dr. Gogineni received a total of $159,647 from 52 companies across 681 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gogineni's costs compare to other internal medicine physicians in Ocala?
Dr. Gogineni's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gogineni) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →